100 related articles for article (PubMed ID: 9364993)
21. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
22. Binding of tissue-type plasminogen activator by the mannose receptor.
Otter M; Barrett-Bergshoeff MM; Rijken DC
J Biol Chem; 1991 Jul; 266(21):13931-5. PubMed ID: 1906888
[TBL] [Abstract][Full Text] [Related]
23. Effect of dextran on plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) during surgery.
Eriksson M; Saldeen T
Acta Anaesthesiol Scand; 1995 Feb; 39(2):163-6. PubMed ID: 7540788
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the hepatic disposition of lanoteplase, a rationally designed variant of tissue plasminogen activator in rodents.
Komoriya K; Kato Y; Hayashi Y; Ohsuye K; Nishigaki R; Sugiyama Y
Drug Metab Dispos; 2007 Mar; 35(3):469-75. PubMed ID: 17178768
[TBL] [Abstract][Full Text] [Related]
25. Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.
Stang E; Roos N; Schlüter M; Berg T; Krause J
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):799-804. PubMed ID: 1323274
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator.
Otter M; Zocková P; Kuiper J; van Berkel TJ; Barrett-Bergshoeff MM; Rijken DC
Hepatology; 1992 Jul; 16(1):54-9. PubMed ID: 1618483
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver.
Otter M; Kuiper J; van Berkel TJ; Rijken DC
Ann N Y Acad Sci; 1992 Dec; 667():431-42. PubMed ID: 1339243
[No Abstract] [Full Text] [Related]
29. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.
Bu G; Williams S; Strickland DK; Schwartz AL
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7427-31. PubMed ID: 1502154
[TBL] [Abstract][Full Text] [Related]
30. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
[TBL] [Abstract][Full Text] [Related]
31. Elimination of native and carbohydrate-modified tissue plasminogen activator in rabbits.
Einarsson M; Hggroth L; Mattsson C
Thromb Haemost; 1989 Dec; 62(4):1088-93. PubMed ID: 2515604
[TBL] [Abstract][Full Text] [Related]
32. The 39-kDa protein regulates LRP activity in cultured endothelial and smooth muscle cells.
Warshawsky I; Schwartz AL
Eur J Cell Biol; 1996 Feb; 69(2):156-65. PubMed ID: 8907616
[TBL] [Abstract][Full Text] [Related]
33. Hepatic clearance of tissue-type plasminogen activator in rats.
Emeis JJ; van den Hoogen CM; Jense D
Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
[TBL] [Abstract][Full Text] [Related]
34. Monensin inhibits recycling of macrophage mannose-glycoprotein receptors and ligand delivery to lysosomes.
Wileman T; Boshans RL; Schlesinger P; Stahl P
Biochem J; 1984 Jun; 220(3):665-75. PubMed ID: 6087792
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated transfer of the 39 kD receptor-associated protein increases fibrinolytic capacity.
Goedde MF; Grimbergen JM; Toet KH; Sitter T; Quax PH; Kooistra T
Kidney Int; 2001 Jul; 60(1):117-25. PubMed ID: 11422743
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
van Giezen JJ; Boon GI; Jansen JW; Bouma BN
Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
[TBL] [Abstract][Full Text] [Related]
37. Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.
Hori R; He YL; Shima T; Inui K; Aoki S; Okumura K; Tanigawara Y
Drug Metab Dispos; 1992; 20(4):541-6. PubMed ID: 1356732
[TBL] [Abstract][Full Text] [Related]
38. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
39. Tissue plasminogen activator is endocytosed by mannose and galactose receptors of rat liver cells.
Smedsrød B; Einarsson M; Pertoft H
Thromb Haemost; 1988 Jun; 59(3):480-4. PubMed ID: 2847350
[TBL] [Abstract][Full Text] [Related]
40. Biochemical determinants of clearance of tissue-type plasminogen activator from the circulation.
Lucore CL; Fry ET; Nachowiak DA; Sobel BE
Circulation; 1988 Apr; 77(4):906-14. PubMed ID: 3127078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
